Patients

If you or someone you care about has been diagnosed with cancer, you may have many questions and concerns. We encourage you to visit the following sites for support and information for people living with cancer, their caregivers, family and friends.

Canadian Cancer Society

American Cancer Society

www.ontariocancertrials.ca (list of clinical studies in Ontario, Canada)

www.clinicaltrials.gov (list of clinical studies in the US)

For information about YM BioSciences' products and ongoing clinical studies, please click the appropriate link below.

 

CYT387

  • Indication: Hematological disorders known as myeloproliferative neoplasms (MPNs), also known as myeloproliferative disorders
  • JAK 1/2 small molecule inhibitor
  • Ongoing Phase I/II and Phase II clinical studies


Nimotuzumab

  • Indication: Cancer
  • Monoclonal antibody
  • Ongoing clinical studies for lung cancer, pediatric and adult brain cancer, esophageal cancer, pancreatic cancer, prostate cancer, gastric cancer, cervical cancer, hepatic carcinoma and breast cancer
  • Approved for sale in certain countries
  • Nimotuzumab has been made available to patients through compassionate use or expanded access programs in many countries including the US, Canada and Europe.


CYT997